South Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic ...

A viral post claims HIV-positive South Africans will get R1,200 a Month! Here’s what the Health Department says ...

South Africa is in discussions with Gilead Sciences (GILD) to reach an agreement that allows the production of the U.S. biotech’s new twice-yearly HIV therapy, lenacapavir, in the country, home to the ...

South Africa is asking local drugmakers to start a process to make Gilead Sciences’ long-acting HIV prevention drug, lenacapavir, domestically, in a push to bring production ‌to the region where it is ...

South Africa has the world’s highest HIV burden, with about 8 million HIV-positive people, or 1 in 5 adults, as of last year.

Add Yahoo as a preferred source to see more of our stories on Google. Patrick Arbuthnot was browsing his emails on what seemed like a normal workday in his lab in Johannesburg when he saw a strange ...

South Africa is advocating for local production of Gilead Sciences’ HIV prevention drug lenacapavir. Collaborating with ...

UMZIMKHULU, South Africa (AP) — At a rural village in South Africa's KwaZulu-Natal province, unemployed 19-year-old Nozuko Majola is trying to figure out if she has enough money for the one-hour ride ...

According to The Witness, statistics released by Thembisa, the mathematical model of HIV and TB in South Africa, show that in ...

Sanac has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids in the country by 2043 ...

South Africa's National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country.